Exact Imaging wins Health Canada approval for FusionVu


Exact Imaging-logoExact Imaging has won Health Canada approval for its FusionVu application that is used for micro-ultrasound/MRI fusion with the ExactVu high resolution micro-ultrasound system.

“We are excited to have received regulatory approval from Health Canada allowing our FusionVu application, a feature of our ExactVu micro-ultrasound system, to be commercially available in Canada,” Randy AuCoin, president and CEO of Exact Imaging, said. “The ExactVu micro-ultrasound system provides the highest real-time resolution for targeted prostate biopsies. Urologists who appreciate the benefit of MRI for select clinical cases, such as patients with repeat negative biopsies but with increasing risk indications, can now have the best of both worlds. The can leverage FusionVu to align the patient’s MRI with the live micro-ultrasound image to either perform Cognitive Assist or micro-ultrasound/MRI fusion-guided biopsies, all with the benefit of the 70-micro resolution of micro-ultrasound.”

The new approval allows Canadian customers to use the FusionVu application. It has already received CE Mark approval for commercial access in Europe and FDA 510(k) clearance for U.S. commercial access.

Inside Hologic's evolving definition of women's healthcare

textadimage Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.

At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!


Use code WOMENSHEALTH to save an additional 10%.

Speak Your Mind